BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31513123)

  • 1. Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel Molecules.
    Sen Gupta A
    Shock; 2019 Oct; 52(1S Suppl 1):70-83. PubMed ID: 31513123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepping stones to the future of haemoglobin-based blood products: clinical, preclinical and innovative examples.
    Coll-Satue C; Bishnoi S; Chen J; Hosta-Rigau L
    Biomater Sci; 2021 Feb; 9(4):1135-1152. PubMed ID: 33350411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers.
    Jansman MMT; Hosta-Rigau L
    Adv Colloid Interface Sci; 2018 Oct; 260():65-84. PubMed ID: 30177214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from studies of blood substitutes in trauma.
    Moore EE; Johnson JL; Cheng AM; Masuno T; Banerjee A
    Shock; 2005 Sep; 24(3):197-205. PubMed ID: 16135956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic studies on oxygen releasing of HBOC and red blood cells as fluids and factors affecting the process.
    Zhao B; Zhang S; Meng Z; Wang D; Li Q; Guo Y; Li F; Wang X; Yang C
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1076-S1082. PubMed ID: 30449264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.
    Jahr JS; Akha AS; Holtby RJ
    Curr Drug Discov Technol; 2012 Sep; 9(3):158-65. PubMed ID: 21745179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin-based oxygen carriers in trauma care: scientific rationale for the US multicenter prehosptial trial.
    Moore EE; Cheng AM; Moore HB; Masuno T; Johnson JL
    World J Surg; 2006 Jul; 30(7):1247-57. PubMed ID: 16710614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present situation of the development of cellular-type hemoglobin-based oxygen carrier (hemoglobin-vesicles).
    Sakai H
    Curr Drug Discov Technol; 2012 Sep; 9(3):188-93. PubMed ID: 21726183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing potential risks and benefits of hemoglobin-based oxygen carriers.
    Weiskopf RB; Silverman TA
    Transfusion; 2013 Oct; 53(10):2327-33. PubMed ID: 23869543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin solutions and tissue oxygenation.
    Muir WW; Wellman ML
    J Vet Intern Med; 2003; 17(2):127-35. PubMed ID: 12683610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of the Need for an Oxygen Carrier for the Treatment of Traumatic Hemorrhage When Blood is not an Option.
    Pusateri AE; Glassberg E; Weiskopf RB
    Shock; 2019 Oct; 52(1S Suppl 1):55-59. PubMed ID: 31348149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.
    Samaja M; Malavalli A; Vandegriff KD
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201.
    Jahr JS; Williams JP
    Am J Ther; 2022 May-Jun 01; 29(3):e279-e286. PubMed ID: 35421008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin-Based Oxygen Carrier (HBOC) Development in Trauma: Previous Regulatory Challenges, Lessons Learned, and a Path Forward.
    Keipert PE
    Adv Exp Med Biol; 2017; 977():343-350. PubMed ID: 28685464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Setbacks in blood substitutes research and development: a biochemical perspective.
    Alayash AI
    Clin Lab Med; 2010 Jun; 30(2):381-9. PubMed ID: 20513557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components.
    Dorman SC; Kenny CF; Miller L; Hirsch RE; Harrington JP
    Artif Cells Blood Substit Immobil Biotechnol; 2002 Jan; 30(1):39-51. PubMed ID: 12000225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.
    Alayash AI
    Shock; 2019 Oct; 52(1S Suppl 1):41-49. PubMed ID: 29112106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoglobin-based erythrocyte transfusion substitutes.
    Standl T
    Expert Opin Biol Ther; 2001 Sep; 1(5):831-43. PubMed ID: 11728218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resuscitation with a hemoglobin-based oxygen carrier after traumatic brain injury.
    King DR; Cohn SM; Proctor KG
    J Trauma; 2005 Sep; 59(3):553-60; discussion 560-2. PubMed ID: 16361895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-inspired nanomedicine strategies for artificial blood components.
    Sen Gupta A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28296287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.